Traduction de «mission marché » (Français → Anglais) :

In order to fully implement the model set out in recent Directives in the securities field, in particular Directive 2003/6/EC of the European Parliament and of the Council of 28 January 2003 on insider dealing and market manipulation (market abuse) , which gives to the ESC the function to advise the Commission in the exercise of its regulatory powers, while leaving the organisation of other aspects of the ESC's work to be governed by Decision 2001/528/EC, it is necessary to delete the provisions setting up, under Article 53 of Directive 85/611/EEC, the organisation and functions of the present UCITS Contact Committee outside its ‘comitol ...[+++]ogy’ capacity.

[English] As well, the hon. parliamentary secretary for new and emerging markets undertook a recent trade mission to Syria, the U.A.E., Qatar, Yemen and Egypt.

[Text] Question No. 26 Mr. John Cummins: With regard to the risk management of the antimalarial drug mefloquine by Health Canada and the Department of National Defence: (a) what deployments since 1990 involved administration of the drug to members of the Canadian Forces; (b) did Health Canada receive from the Canadian Forces adverse drug event reports for each such deployment either during or immediately following deployment; (c) how many Canadians received the drug under Health Canada’s Lariam Safety Monitoring Study; (d) how many patients were the subject of monitoring reports received by Health Canada directly or indirectly from Roche under the Lariam Safety Monitoring Study; (e) what types of adverse events were identified by the La ...[+++]riam Safety Monitoring Study up to the time the drug was licensed in 1993; (f) what is the total number of adverse events reported to Health Canada since the commencement of marketing in 1993; (g) how many adverse events were reported to Health Canada since the commencement of the marketing of the drug in 1993 involving each of the following reactions - hallucinations, panic reaction, hyper alertness, extreme excitability, convulsions, aggressive reaction, marked restlessness, suicide, suicidal tendency, suicide attempt, thoughts of self harm, abnormal dreams, emotional disorder, irritability, nightmares, abnormal thinking, anxiety, depressed state, aggravated depression, light-headedness, anxiety attack, mood swings, abnormal crying, psychosis, delusion, speech disorder, concentration impaired, fear, euphoria, hysteria, paranoid psychosis, memory impairment, emotional disorder, murder; (h) what measures have been taken by Health Canada to ensure that it receives notice of such adverse drug events from doctors administering the drug; (i) what changes to the product monograph have been approved by Health Canada since licensing of the drug in 1993; (j) how many Canadian Forces members deployed on special missions abroad since 1 ...

Q-26 — Mr. Cummins (Delta—South Richmond) — With regard to the risk management of the antimalarial drug mefloquine by Health Canada and the Department of National Defence: (a) what deployments since 1990 involved administration of the drug to members of the Canadian Forces; (b) did Health Canada receive from the Canadian Forces adverse drug event reports for each such deployment either during or immediately following deployment; (c) how many Canadians received the drug under Health Canada’s Lariam Safety Monitoring Study; (d) how many patients were the subject of monitoring reports received by Health Canada directly or indirectly from Roche under the Lariam Safety Monitoring Study; (e) what types of adverse events were identified by the ...[+++] Lariam Safety Monitoring Study up to the time the drug was licensed in 1993; (f) what is the total number of adverse events reported to Health Canada since the commencement of marketing in 1993; (g) how many adverse events were reported to Health Canada since the commencement of the marketing of the drug in 1993 involving each of the following reactions - hallucinations, panic reaction, hyper alertness, extreme excitability, convulsions, aggressive reaction, marked restlessness, suicide, suicidal tendency, suicide attempt, thoughts of self harm, abnormal dreams, emotional disorder, irritability, nightmares, abnormal thinking, anxiety, depressed state, aggravated depression, light-headedness, anxiety attack, mood swings, abnormal crying, psychosis, delusion, speech disorder, concentration impaired, fear, euphoria, hysteria, paranoid psychosis, memory impairment, emotional disorder, murder; (h) what measures have been taken by Health Canada to ensure that it receives notice of such adverse drug events from doctors administering the drug; (i) what changes to the product monograph have been approved by Health Canada since licensing of the drug in 1993; (j) how many Canadian Forces members deployed on special missions abroad sinc ...

NRAs will not define the geographic scope of any transnational markets, as any Decision on transnational markets will define their geographic dimension,

The Governments of the Member States and the European Commission were represented as follows: Belgium: Mr Melchior WATHELET Deputy Prime Minister, Minister for Justice and Economic Affairs Mr Vic ANCIAUX State Secretary with responsibility for Energy (Brussels Regional Executive) Denmark: Mr Svend AUKEN Minister for the Environment and Energy Germany: Mr Günther REXRODT Minister for Economic Affairs Mr Dieter von WÜRZEN State Secretary, Federal Ministry of Economic Affairs Greece: Mr Anastasse MANTELIS Secretary-General, Ministry of Energy Spain: Mr Juan Manuel EGUIAGARAY Minister for Industry and Energy France: Mr Pierre SELLAL Deputy P ...[+++]ermanent Representative Ireland: Mr John LOUGHREY Secretary, Department of Transport, Energy and Communications Italy: Mr Roberto ROSSI Deputy Permanent Representative Luxembourg: Mr Robert GOEBBELS Minister for Economic Affairs, Public Works and Energy Netherlands: Mr Lambert J. HANRATH Deputy Permanent Representative Portugal: Mr Luis Filipe PEREIRA State Secretary for Energy United Kingdom: Mr Timothy EGGAR Minister of State, Department of Trade and Industry (Minister for Industry and Energy) Commission: Mr Marcelino OREJA AGUIRRE Member The following representatives of the acceding States attended: Austria: Mrs Judith GEBETSROITHNER Deputy Head of Mission Finland: Mr Jan STORE Deputy Head of Mission Sweden: Mr Jorgen ANDERSSON Minister with responsibility for Housing and Energy ------------ INTERNAL MARKET IN ELECTRICITY - COUNCIL CONCLUSIONS After an extensive exchange of views on the proposal for a Directive concerning common rules for the internal market in electricity, the Council adopted the following conclusions: "After the submission of the amended proposals for directives on common rules for the internal market for electricity and natural gas by the Commission in response to the position of the European Parliament and the conclusions of the Council on 30 November 1992 the Council has concluded the following: 1.